Clinical Trial Update: Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating minocycline for HIV-associated cognitive impairment in HIV-infected adults was terminated; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hiv-associated Neurocognitive Disorder

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV Infections | Phase 2 | Status: TERMINATED | Results posted: 2011-07-26